Annual EBITDA:
-$101.45M-$53.63M(-112.16%)Summary
- As of today (October 5, 2025), DNTH annual EBITDA is -$101.45 million, with the most recent change of -$53.63 million (-112.16%) on December 31, 2024.
- During the last 3 years, DNTH annual EBITDA has fallen by -$28.78 million (-39.60%).
- DNTH annual EBITDA is now -995.36% below its all-time high of -$9.26 million, reached on December 1, 2016.
Performance
DNTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$34.83M-$1.78M(-5.40%)Summary
- As of today (October 5, 2025), DNTH quarterly EBITDA is -$34.83 million, with the most recent change of -$1.78 million (-5.40%) on June 30, 2025.
- Over the past year, DNTH quarterly EBITDA has dropped by -$12.73 million (-57.64%).
- DNTH quarterly EBITDA is now -628.92% below its all-time high of -$4.78 million, reached on March 1, 2017.
Performance
DNTH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$129.49M-$12.73M(-10.91%)Summary
- As of today (October 5, 2025), DNTH TTM EBITDA is -$129.49 million, with the most recent change of -$12.73 million (-10.91%) on June 30, 2025.
- Over the past year, DNTH TTM EBITDA has dropped by -$61.07 million (-89.26%).
- DNTH TTM EBITDA is now -2610.21% below its all-time high of -$4.78 million, reached on March 1, 2017.
Performance
DNTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNTH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -112.2% | -57.6% | -89.3% |
| 3Y3 Years | -39.6% | -106.2% | -68.5% |
| 5Y5 Years | -25.1% | -78.5% | -57.3% |
DNTH EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -243.2% | at low | -358.1% | at low | -219.7% | at low |
| 5Y | 5-Year | -243.2% | at low | -358.1% | at low | -219.7% | at low |
| All-Time | All-Time | -995.4% | at low | -628.9% | at low | -2610.2% | at low |
DNTH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$34.83M(+5.4%) | -$129.49M(+10.9%) |
| Mar 2025 | - | -$33.04M(+3.8%) | -$116.76M(+15.1%) |
| Dec 2024 | -$101.45M(+112.2%) | -$31.84M(+6.9%) | -$101.45M(+23.0%) |
| Sep 2024 | - | -$29.78M(+34.8%) | -$82.47M(+20.5%) |
| Jun 2024 | - | -$22.09M(+24.6%) | -$68.42M(+17.9%) |
| Mar 2024 | - | -$17.74M(+38.0%) | -$58.02M(+21.2%) |
| Dec 2023 | -$47.82M(+61.8%) | -$12.85M(-18.3%) | -$47.89M(+4.8%) |
| Sep 2023 | - | -$15.74M(+34.6%) | -$45.68M(+12.8%) |
| Jun 2023 | - | -$11.69M(+53.8%) | -$40.50M(-11.4%) |
| Mar 2023 | - | -$7.60M(-28.6%) | -$45.70M(-24.7%) |
| Dec 2022 | -$29.56M(-59.3%) | -$10.64M(+0.8%) | -$60.72M(-12.9%) |
| Sep 2022 | - | -$10.56M(-37.5%) | -$69.68M(-9.3%) |
| Jun 2022 | - | -$16.89M(-25.4%) | -$76.83M(-0.3%) |
| Mar 2022 | - | -$22.62M(+15.4%) | -$77.07M(+6.1%) |
| Dec 2021 | -$72.67M | - | - |
| Dec 2021 | - | -$19.61M(+10.7%) | -$72.67M(+1.4%) |
| Sep 2021 | - | -$17.71M(+3.4%) | -$71.64M(-0.2%) |
| Jun 2021 | - | -$17.13M(-6.0%) | -$71.81M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$18.22M(-1.9%) | -$74.20M(-3.3%) |
| Dec 2020 | -$76.72M(-5.4%) | -$18.57M(+3.8%) | -$76.72M(-6.8%) |
| Sep 2020 | - | -$17.89M(-8.4%) | -$82.31M(-4.9%) |
| Jun 2020 | - | -$19.52M(-5.9%) | -$86.58M(+0.7%) |
| Mar 2020 | - | -$20.75M(-14.1%) | -$85.95M(+5.9%) |
| Dec 2019 | -$81.13M(+37.3%) | -$24.15M(+9.0%) | -$81.13M(+8.8%) |
| Sep 2019 | - | -$22.16M(+17.3%) | -$74.55M(+8.2%) |
| Jun 2019 | - | -$18.89M(+18.6%) | -$68.88M(+7.9%) |
| Mar 2019 | - | -$15.93M(-9.4%) | -$63.86M(+8.1%) |
| Dec 2018 | -$59.09M(+67.1%) | -$17.57M(+6.5%) | -$59.09M(+42.3%) |
| Sep 2018 | - | -$16.49M(+19.0%) | -$41.52M(+30.1%) |
| Jun 2018 | - | -$13.87M(+24.2%) | -$31.92M(-5.3%) |
| Mar 2018 | - | -$11.16M(+61.8%) | -$33.69M(+23.4%) |
| Dec 2017 | -$35.35M(+281.7%) | - | - |
| Sep 2017 | - | -$6.90M(-55.9%) | -$27.31M(+33.8%) |
| Jun 2017 | - | -$15.63M(+227.2%) | -$20.41M(+327.2%) |
| Mar 2017 | - | -$4.78M | -$4.78M |
| Dec 2016 | -$9.26M | - | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Dianthus Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Dianthus Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of DNTH is -$101.45M
What is the all-time high annual EBITDA for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual EBITDA is -$9.26M
What is Dianthus Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, DNTH annual EBITDA has changed by -$53.63M (-112.16%)
What is Dianthus Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of DNTH is -$34.83M
What is the all-time high quarterly EBITDA for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly EBITDA is -$4.78M
What is Dianthus Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, DNTH quarterly EBITDA has changed by -$12.73M (-57.64%)
What is Dianthus Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of DNTH is -$129.49M
What is the all-time high TTM EBITDA for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high TTM EBITDA is -$4.78M
What is Dianthus Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, DNTH TTM EBITDA has changed by -$61.07M (-89.26%)